703 related articles for article (PubMed ID: 15660766)
1. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
[TBL] [Abstract][Full Text] [Related]
2. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures.
Sackellares JC; Ramsay RE; Wilder BJ; Browne TR; Shellenberger MK
Epilepsia; 2004 Jun; 45(6):610-7. PubMed ID: 15144425
[TBL] [Abstract][Full Text] [Related]
3. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial.
Brodie MJ; Rosenfeld WE; Vazquez B; Sachdeo R; Perdomo C; Mann A; Arroyo S
Epilepsia; 2009 Aug; 50(8):1899-909. PubMed ID: 19490053
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
Elger C; Halász P; Maia J; Almeida L; Soares-da-Silva P;
Epilepsia; 2009 Mar; 50(3):454-63. PubMed ID: 19243424
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
6. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
Shinnar S; Pellock JM; Conry JA
Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
[TBL] [Abstract][Full Text] [Related]
7. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
[TBL] [Abstract][Full Text] [Related]
8. Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.
Ben-Menachem E; Gabbai AA; Hufnagel A; Maia J; Almeida L; Soares-da-Silva P
Epilepsy Res; 2010 May; 89(2-3):278-85. PubMed ID: 20299189
[TBL] [Abstract][Full Text] [Related]
9. Zonisamide as adjunctive therapy for refractory partial seizures.
Brodie MJ
Epilepsy Res; 2006 Feb; 68 Suppl 2():S11-6. PubMed ID: 16316744
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures.
Gil-Nagel A; Lopes-Lima J; Almeida L; Maia J; Soares-da-Silva P;
Acta Neurol Scand; 2009 Nov; 120(5):281-7. PubMed ID: 19832771
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
[TBL] [Abstract][Full Text] [Related]
12. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
Baulac M; Leppik IE
Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
[TBL] [Abstract][Full Text] [Related]
15. A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures.
Elger CE; Stefan H; Mann A; Narurkar M; Sun Y; Perdomo C
Epilepsy Res; 2010 Feb; 88(2-3):255-63. PubMed ID: 20061123
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
[TBL] [Abstract][Full Text] [Related]
17. A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy.
Guerrini R; Rosati A; Segieth J; Pellacani S; Bradshaw K; Giorgi L
Epilepsia; 2013 Aug; 54(8):1473-80. PubMed ID: 23837461
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
French JA; Krauss GL; Steinhoff BJ; Squillacote D; Yang H; Kumar D; Laurenza A
Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
[TBL] [Abstract][Full Text] [Related]
19. Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures.
Elger C; Bialer M; Cramer JA; Maia J; Almeida L; Soares-da-Silva P
Epilepsia; 2007 Mar; 48(3):497-504. PubMed ID: 17319919
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of levetiracetam: a review of three pivotal clinical trials.
Privitera M
Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
